Andere Sprachen Hyphens Pharma International Limited

Aktien

A2QAM8

SG1EE4000006

1J5

Verzögert Singapore S.E. Andere Börsenplätze 03:16:41 06.06.2024			% 5 Tage	% 1. Jan.
0,29 ^SGD	+1,75 %		+3,57 %	+1,75 %

06.06.	Singapur-Aktien bleiben trotz der über Nacht erzielten Gewinne an den globalen Märkten flach; Zheneng Jinjiang steigt um 3%	MT
06.06.	Tochtergesellschaft von Hyphens Pharma schließt Exklusivvertrag mit Maruho ab	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Singapore Shares Remain Flat Despite Overnight Gains in Global Markets; Zheneng Jinjiang Rises 3%	06.06.
Hyphens Pharma’s Subsidiary Enters Exclusive Deal with Maruho	06.06.
Singapore Shares Drop in Red Despite Global Rally; Biolidics Surges 20% on Wider Losses in Q1	15.05.
Hyphens Pharma's Q1 Net Profit Nearly Doubles on Broad-Based Sales Growth; Stock Climbs 6%	15.05.
Hyphens Pharma International Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	14.05.
Hyphens Pharma International Limited Approves a Final Tax Exempt (One-Tier) Dividend for the Financial Year Ended 31 December 2023	25.04.
Hyphens Pharma International Limited's Equity Buyback announced on April 2, 2024, has expired.	25.04.
Hyphens Pharma’s Attributable Profit Narrows in 2023	09.04.
Hyphens Pharma International Limited Proposes Final Tax Exempt (One-Tier) Dividend	09.04.
Hyphens Pharma Buys Back Shares	03.04.
Hyphens Pharma International Limited commences an Equity Buyback Plan for 30,877,620 shares, representing 10% of its issued share capital, under the authorization approved on April 26, 2023.	02.04.
Hyphens Pharma licenses Wynzora Cream for ASEAN countries from MC2 Therapeutics	13.03.
MC2 Therapeutics Announces License, Supply and Commercialization Agreement for Wynzora Cream in ASEAN Countries	13.03.
Hyphens Pharma Obtains License to MC2's Psoriasis Cream	13.03.
Hyphens Pharma International Limited Signs Exclusive Distribution Agreement with Cooper Pharma, S.A	29.02.
Hyphens Pharma International Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27.02.
Hyphens Pharma Strikes Distribution Deal With 7-Eleven Singapore	13.02.
Hyphens Pharma Partners 7-Eleven to Offer Ocean Health Supplements in Singapore	06.02.
Hyphens Pharma International Grants Nearly 6 Million Shares Under Performance Share Plan	11.12.
Hyphens Pharma International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Hyphens Pharma International Limited

Aktien

A2QAM8

SG1EE4000006

1J5

Andere Sprachen

Filter